These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
778 related articles for article (PubMed ID: 12036924)
1. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924 [TBL] [Abstract][Full Text] [Related]
2. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells. Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907 [TBL] [Abstract][Full Text] [Related]
3. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Benaud CM; Dickson RB Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780 [TBL] [Abstract][Full Text] [Related]
6. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Dhillon NK; Mudryj M Oncogene; 2002 Jul; 21(30):4626-34. PubMed ID: 12096339 [TBL] [Abstract][Full Text] [Related]
11. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267 [TBL] [Abstract][Full Text] [Related]
12. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551 [TBL] [Abstract][Full Text] [Related]
13. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
14. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ; Chang CY; Lin JK Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329 [TBL] [Abstract][Full Text] [Related]
15. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. Carroll JS; Prall OW; Musgrove EA; Sutherland RL J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938 [TBL] [Abstract][Full Text] [Related]
16. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745 [TBL] [Abstract][Full Text] [Related]
17. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049 [TBL] [Abstract][Full Text] [Related]